The Global Fund to Fight AIDS, Tuberculosis and Malaria
Tracked across 2 events · 16 articles · First seen Apr 03, 2026 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
International
Impact: The The Global Fund to Fight AIDS, Tuberculosis and Malaria is a major global institution that will engage with the Accra Reset's panel through a High-Level Consultative Group, and its Executive Director is a member of this group.
Apr 03, 2026 · 8 articles
Tech
South Africa has launched the rollout of Lenacapavir, a highly effective, twice-yearly injectable drug for HIV prevention, marking a significant turning point in the country's fight against HIV. Developed by Gilead Sciences, Lenacapavir demonstrated 100%…
Impact: The The Global Fund to Fight AIDS, Tuberculosis and Malaria provided a $29 million grant to South Africa to acquire doses of Lenacapavir for 456,000 people for a year.
Jun 09, 2026 · 8 articles
NEWSDESK
Track The Global Fund to Fight AIDS, Tuberculosis and Malaria live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard